Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J Phelan

Bevacizumab Combined With Gemcitabine and Capecitabine for Advanced Pancreatic Cancer: A Phase II Study

British Journal of Cancer

Cancer Research

Oncology

2009

English

Lifetime and Five-Year Prevalence of Homelessness in the United States.

American Journal of Public Health

English

Related publications

Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study

British Journal of Cancer

Cancer Research

Oncology

2006

English

Gemcitabine Combined With Capecitabine Compared to Gemcitabine With or Without Erlotinib as First-Line Chemotherapy in Patients With Advanced Pancreatic Cancer

Cancer Research and Treatment

Cancer Research

Oncology

2014

English

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Journal of Clinical Oncology

English

A Multicentre Randomised Phase II Trial of Gemcitabine Alone vs Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: GEMSAP Study

British Journal of Cancer

Cancer Research

Oncology

2012

English

A Phase II Trial of Fixed-Dose Rate Gemcitabine Plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients

English

A Phase I Study of Imexon Plus Gemcitabine as First-Line Therapy for Advanced Pancreatic Cancer

Cancer Chemotherapy and Pharmacology

English

Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study

Investigational New Drugs

Oncology

Pharmacology

2015

English

Meta-Analysis of Randomized Phase II and Phase III Trials of Gemcitabine With/Without S-1 in Asian Patients With Advanced Pancreatic Cancer.

Journal of Clinical Oncology

English

A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

Clinical Colorectal Cancer

Oncology

Gastroenterology

2011

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J Phelan

Bevacizumab Combined With Gemcitabine and Capecitabine for Advanced Pancreatic Cancer: A Phase II Study

Lifetime and Five-Year Prevalence of Homelessness in the United States.

Related publications

Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study

Gemcitabine Combined With Capecitabine Compared to Gemcitabine With or Without Erlotinib as First-Line Chemotherapy in Patients With Advanced Pancreatic Cancer

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

A Multicentre Randomised Phase II Trial of Gemcitabine Alone vs Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: GEMSAP Study

A Phase II Trial of Fixed-Dose Rate Gemcitabine Plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients

A Phase I Study of Imexon Plus Gemcitabine as First-Line Therapy for Advanced Pancreatic Cancer

Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study

Meta-Analysis of Randomized Phase II and Phase III Trials of Gemcitabine With/Without S-1 in Asian Patients With Advanced Pancreatic Cancer.

A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer